Get the app
NSEHealthcare

Healthcare Global Enterprises Limited (HCG)

NSE · Healthcare · Medical Care Facilities

₹687.15+1.93%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹693 cr
Revenue YoY
+13.1%
Net profit
₹14 cr
Profit YoY
+189.9%
EPS
₹0.92
EPS estimate
₹2.90
Net margin
2.0%

EPS came in at 0.92 against a street estimate of 2.90 — a miss of 68.3%.

Key statistics

Market cap
₹10,360 cr
P/E
453.5
Forward P/E
0.0
P/B
7.78
Book value
₹92.07
EPS (TTM)
₹1.53
52-week high
₹804.65
52-week low
₹513.30
50-day MA
₹689.42
200-day MA
₹630.59
Beta
-0.03

Analyst view

with an average price target of ₹806.80.

Shareholding

Promoters
70.64%
Institutions
19.08%

Recent filings & reports

DocumentDate
Annual report FY2026
HEALTHCARE GLOBAL ENTERPRISES LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • 28th Annual General Meeting scheduled: Friday, September 18, 2026, at 5:
2026-08-27
Q1 FY27 earnings call
HEALTHCARE GLOBAL ENTERPRISES LIMITED – Q1 FY27 SUMMARY --- HEADLINE NUMBERS • Revenue: INR 6,951 million (Q1 FY27), representing 13% year-on-year
2026-08-10
Quarterly results · Q1 FY27
HCG Q1 FY27 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹6,951 million in Q1 FY27, up 13% year-on-year from ₹6,132 million
2026-08-06
Investor presentation · Q1 FY27
HEALTHCARE GLOBAL ENTERPRISES LIMITED – Q1 FY2027 SUMMARY HEADLINE NUMBERS • Total Revenue: INR 6,951 Mn in Q1 FY27, up 13% year-on-year • Adjusted
2026-08-06
Q4 FY26 earnings call
HEALTHCARE GLOBAL ENTERPRISES LIMITED - FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Q4 FY26 Revenue: INR 652 crore, up 11.3% year-on-year • FY26 Full Y
2026-05-26
Quarterly results · Q4 FY26
HEALTHCARE GLOBAL ENTERPRISES LIMITED – FY26 SUMMARY HEADLINE NUMBERS • Revenue from Operations (FY26): Rs. 25,454 million, up 15% year-on-year from
2026-05-19
Investor presentation
HEALTHCARE GLOBAL ENTERPRISES LIMITED – FY26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • FY26 Revenue: INR 25,454 Mn, up 15% YoY (Q4FY26: INR 6,
2026-05-19
Q3 FY26 earnings call
HEALTHCARE GLOBAL ENTERPRISES LIMITED Q3 & 9M FY26 EARNINGS SUMMARY --- HEADLINE NUMBERS • Q3 FY26 Revenue: INR 633 crore (13.4% YoY growth); Exclu
2026-02-13

Readable in the app.

Corporate actions

ActionDetailDate
Rights issue1 : 17
ex-date Mar 2, 2026
2026-03-02

Deals & corporate news

AnnouncementDate
Subsidiary acquires 26% equity stake in renewable energy company
Healthcare Global Enterprises Limited (HCG), through its subsidiary HCG Manavata Oncology LLP, is acquiring a 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited (EVRE) for
2026-08-04
Launch of new 132-bed comprehensive cancer hospital in Hebbal
Healthcare Global Enterprises Limited (HGE) has announced the opening of a new comprehensive cancer hospital in Hebbal, Bengaluru, with a capacity of up to 132 beds. This facility will provi
2026-05-19
Completed acquisition of additional 34% stake in Vizag Hospital
Healthcare Global Enterprises Limited has completed the acquisition of an additional 34% stake in Vizag Hospital and Cancer Research Centre Private Limited. This brings the company's total o
2026-04-13
Board approves investments in oncology subsidiary and additional stake acquisition
Healthcare company approved investments totaling Rs. 253.66 crore across two oncology-focused ventures. First, Rs. 98 crore will be invested in HCG NCHRI Oncology LLP, a wholly-owned subsidi
2026-03-30
Second amendment agreement executed for Vizag Hospital acquisition
HealthCare Global Enterprises Limited (HCG) has executed second amendment agreements related to its previously announced acquisition of Vizag Hospital and Cancer Research Centre Private Limi
2026-03-29

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Healthcare Global Enterprises Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.